AU2155995A - New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension - Google Patents

New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Info

Publication number
AU2155995A
AU2155995A AU21559/95A AU2155995A AU2155995A AU 2155995 A AU2155995 A AU 2155995A AU 21559/95 A AU21559/95 A AU 21559/95A AU 2155995 A AU2155995 A AU 2155995A AU 2155995 A AU2155995 A AU 2155995A
Authority
AU
Australia
Prior art keywords
glaucoma
treatment
ocular hypertension
prostaglandin derivatives
new prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21559/95A
Inventor
Bahram Resul
Johan Stjernschantz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU2155995A publication Critical patent/AU2155995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU21559/95A 1994-03-31 1995-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension Abandoned AU2155995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9401087 1994-03-31
SE9401087A SE9401087D0 (en) 1994-03-31 1994-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
PCT/SE1995/000347 WO1995026729A1 (en) 1994-03-31 1995-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Publications (1)

Publication Number Publication Date
AU2155995A true AU2155995A (en) 1995-10-23

Family

ID=20393491

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21559/95A Abandoned AU2155995A (en) 1994-03-31 1995-03-31 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Country Status (3)

Country Link
AU (1) AU2155995A (en)
SE (1) SE9401087D0 (en)
WO (1) WO1995026729A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
EP0869794B1 (en) * 1995-12-22 2004-08-11 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
AU5436198A (en) * 1996-11-12 1998-06-03 Alcon Laboratories, Inc. 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
SE9900672D0 (en) * 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
US7183310B2 (en) * 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
DK1960353T3 (en) 2005-11-03 2014-05-26 Allergan Inc Prostaglandins and analogues as agents for lowering intraocular pressure
US8193373B2 (en) 2006-12-11 2012-06-05 Allergan, Inc. Therapeutic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029693A (en) * 1975-01-20 1977-06-14 The Upjohn Company 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters
US4061670A (en) * 1976-07-19 1977-12-06 American Cyanamid Company 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners
GB1595998A (en) * 1977-03-30 1981-08-19 American Cyanamid Co Prostenoic acids and esters
EP1224934A3 (en) * 1988-09-06 2003-03-26 Pharmacia AB Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE120188T1 (en) * 1990-03-08 1995-04-15 Shionogi & Co 15-DEOXYPROSTAGLAND INDERIVATE.

Also Published As

Publication number Publication date
SE9401087D0 (en) 1994-03-31
WO1995026729A1 (en) 1995-10-12

Similar Documents

Publication Publication Date Title
AU1709699A (en) 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
AU5436198A (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AUPM537994A0 (en) Early detection of glaucoma
EP1224934A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
IL133871A0 (en) Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
AU5258698A (en) 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
AU6613990A (en) Thiazolidine derivatives for the treatment of hypertension
AU3628395A (en) Benz{g}indazolyl derivatives for the treatment of inflaminflammation
AU2211700A (en) Prostaglandin e agonists for treatment of glaucoma
AU3145795A (en) Fibrin-cell suspension for construction of new tissue
AU2155995A (en) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU6446698A (en) Removal of corneal epithelium
IL125002A0 (en) Novel substituted 4-(1H-benzimidazol-2-yl) [1,4] diazepanes useful for the treatment of allergic diseases
AU4976599A (en) Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives
AU1450392A (en) Small peptidic compounds useful for the treatment of glaucoma
AU5261898A (en) Tgfalpha for the treatment of ocular hypertension and glaucoma
AU3137095A (en) Ophthalmic compositions for treating glaucoma
AU1043699A (en) Regulation of ocular angiogenesis
AU6376894A (en) Use of substituted alkyl nitrates for the treatment of pathologically increased intra-ocular pressure
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU5430894A (en) Diagnosis of eye disorders
AU7985698A (en) Methods for treatment of ocular neovascularization